Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the United States.1Approximately 25% of people aged 65 years and older have some manifestation of this disease, including large or confluent drusen, retinal pigmentary changes, geographic atrophy, and exudative disease.2Since the elderly make up an increasing proportion of the population, it is estimated that 6.3 million persons will have AMD by the year 2030. This disease, therefore, has important implications for the individual patient as well as the general public. At present, the causes of AMD are unknown and we therefore cannot prevent it. We do not fully understand factors leading to its progression, so early stages cannot be arrested. The only proven method of treatment, laser photocoagulation, is effective for only a small fraction of patients, and vision is often impaired despite treatment.3For these reasons, antioxidant vitamins and minerals represent particularly
No takes yet. Share an insight, caveat, or question.
Johanna M. Seddon (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: